38 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Cancer Genetics Inc CGIX shares climbed 187.5% to $5.98 after the company announced it has retained H.C. Wainwright to explore strategic alternatives.
  • Diffusion Pharmaceuticals Inc DFFN shares gained 115.5% to $0.4739 after the company reported increased survival rates in the lead-in portion of the Phase 3 Glioblastoma study.
  • Aravive, Inc. ARAV shares climbed 93.4% to $12.59 after the company reported new positive data from its Phase 1b trial of AVB-500. The data from the study affirmed high levels of AVB-500 were strongly predictive of anti-tumor activity with statistically significant correlation to progression-free survival, which is the primary endpoint.
  • Kiniksa Pharmaceuticals, Ltd. KNSA gained 20.9% to $8.39 after the company received FDA breakthrough therapy designation for its Rilonacept to treat recurrent pericarditis.
  • Fluent Inc FLNT rose 15.2% to $1.6350 after announcing a $5 million buyback plan.
  • Intelsat S.A. I rose 14.8% to $6.99 after falling 24.16% on Tuesday.
  • Arcimoto, Inc. FUV gained 14.4% to $2.4255.
  • Canopy Growth Corporation CGC climbed 13.9% to $17.45. Bank of America upgraded the stock to Buy and said "the worst is over" for the company's operations.
  • CytomX Therapeutics, Inc. CTMX gained 13% to $5.85. Guggenheim initiated coverage on CytomX Therapeutics with a Buy rating and a $16 price target.
  • Target Corporation TGT rose 12.7% to $124.96 after the company posted upbeat Q3 results and raised FY19 EPS guidance.
  • Aurora Cannabis Inc. ACB gained 12.2% to $2.6251 after the company strengthened up its leadership team by adding a Chief Product Officer and Chief Integration Officer.
  • BioXcel Therapeutics, Inc. BTAI surged 11.7% to $7.19.
  • Akebia Therapeutics, Inc. AKBA gained 11% to $3.53.
  • Celyad SA CYAD gained 10.2% to $12.12 after gaining 20.09% on Tuesday.
  • OrganiGram Holdings Inc. OGI shares rose 9.2% to $2.5323.
  • Tricida, Inc. TCDA shares rose 9.1% to $40.58.
  • ChromaDex Corporation CDXC gained 8.9% to $3.79. ChromaDex announced that the European Commission has voted in favor of listing Nicotinamide Riboside Chloride as a novel food.
  • Mersana Therapeutics, Inc. MRSN surged 8.9% to $2.83.
  • Village Farms International, Inc. VFF rose 8.3% to $6.80.
  • Forty Seven, Inc. FTSV gained 7.6% to $11.81.
  • Endo International PLC ENDP rose 6.7% to $4.75 after the company announced the FDA has accepted for review the original Biologics License Application for collagenase clostridium histolyticum.
  • Lowe's Companies, Inc. LOW rose 5% to $119.04. Lowe's reported upbeat earnings for its third quarter, while sales missed estimates.


Check out these big penny stock gainers and losers

Losers

  • LAIX Inc. LAIX dropped 26.6% to $2.40 after the company reported Q3 results.
  • Berry Petroleum Corp BRY tumbled 20.1% to $7.11 after multiple firms downgraded the stock.
  • Pinduoduo Inc. PDD shares dipped 18% to $33.38 after the company announced a wider Q3 loss.
  • Checkpoint Therapeutics Inc CKPT fell 16.3% to $1.28. Checkpoint Therapeutics priced its 13.4 million share common stock offering at $1.27 per share.
  • Senmiao Technology Limited AIHS dropped 15.4% to $0.7025 as a potential sell-off after the stock increased roughly 230% on November 14th following the company reporting Q2 EPS and sales results up from last year.
  • Urban Outfitters, Inc. URBN fell 14.4% to $24.66 after the company reported worse-than-expected Q3 EPS and sales results.
  • McEwen Mining Inc MUX fell 13.9% to $1.30 after the company announced an offering of common stock and warrants.
  • PagSeguro Digital Ltd. PAGS fell 11.5% to $32.52.
  • SAExploration Holdings, Inc. SAEX shares dropped 9.8% to $2.4798.
  • LexinFintech Holdings Ltd. LX tumbled 8.8% to $11.79.
  • Amarin Corporation plc AMRN fell 8.7% to $20.75. Oppenheimer initiated coverage on Amarin with an Underperform rating and a $7 price target.
  • Plus Therapeutics, Inc. PSTV dropped 8.7% to $1.9179.
  • Qudian Inc. QD fell 8.6% to $5.14 after Macquarie downgraded the stock from Neutral to Underperform.
  • Acasti Pharma Inc. ACST shares fell 7.7% to $2.0949 after gaining 5.58% on Tuesday.
  • Organogenesis Holdings Inc ORGO fell 7% to $7.41 after the company reported a 9 million share common stock offering.
  • Clovis Oncology, Inc. CLVS fell 5.6% to $7.36 after climbing 10.34% on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralConsumer DiscretionaryHome Improvement RetailMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!